Senores Pharmaceuticals, a global research-driven pharmaceutical company, has filed a draft red herring prospectus (DRHP) with the market regulator, the Securities and Exchange Board of India (SEBI), to float an IPO comprising a fresh issue and offer for sale (OFS). Senores Pharmaceuticals IPO to raise ₹500 crore via fresh issue, and the selling shareholders will …